New ir spectroscopy
Download as PPT, PDF4 likes105 views
This document provides information about a presentation on IR spectroscopy. It was presented by Patil Pranjay Sadashiv, a first year M.Pharm student from the Department of Quality Assurance at H. R. Patel Institute of Pharmaceutical Education and Research in Shirpur.
1 of 37
Download to read offline
Recommended
Validation regulatory review
Validation regulatory reviewPRANJAY PATIL
Ìý
The document provides an overview of process validation for pharmaceutical manufacturing. It defines validation as establishing documented evidence that a process will consistently produce a product meeting predetermined specifications. The objectives, types, and stages of validation are described. Key validation documentation like protocols, reports and master plans are summarized. Regulatory requirements for validation from agencies like FDA, EU, WHO and PIC/S are highlighted. The conclusion emphasizes that validation is critical for ensuring product quality and compliance.Total quality management
Total quality managementPRANJAY PATIL
Ìý
This document provides an overview of total quality management (TQM) concepts including:
- Definitions of quality from Joseph Juran and Philip Crosby
- The evolution of quality management approaches from inspection to TQM
- Key elements and principles of TQM from thinkers like Deming, Juran, and Crosby such as continuous improvement, customer focus, and employee involvement
- Frameworks for quality management including Deming's PDCA cycle and Juran's quality trilogyTechnology transfer
Technology transferPRANJAY PATIL
Ìý
This document discusses technology transfer in the pharmaceutical industry. It begins with an introduction defining technology transfer and its importance in transferring scientific findings from research to production. It then discusses types of technology, content of technology transfer including six Ps, steps involved, functions of technology transfer teams, and factors affecting technology transfer. The document provides examples and lists institutions in India that assist with technology transfer. It concludes that effective technology transfer helps provide process efficiency and maintain product quality when moving from drug discovery to commercialization.Technology transfer
Technology transferPRANJAY PATIL
Ìý
This document discusses technology transfer in the pharmaceutical industry. It begins by defining technology transfer as the process of applying technology developed in one organization or context to another. It then discusses the various aspects, types, and classifications of technology. The document focuses on the steps and processes involved in technology transfer for pharmaceutical development, including the research, development, and production phases. It outlines the key documentation and plans required for successful technology transfer, including development reports, specifications, transfer plans, and reports. The document emphasizes that effective communication and validation are important for technology transfer to ensure quality and consistency across organizations.Snda
SndaPRANJAY PATIL
Ìý
The document discusses guidelines for supplemental new drug applications (sNDAs) submitted to the FDA for post-approval changes. It categorizes changes as major, moderate or minor based on their potential impact. Major changes like new manufacturing sites or processes require prior approval. Moderate changes require submission 30 days before distribution or when received by FDA. Minor changes are described in annual reports. The types and levels of data required to support each change category are also outlined.new drug application
new drug applicationPRANJAY PATIL
Ìý
- The document presents information on the New Drug Application (NDA) process required by the FDA to obtain approval to market a new drug product in the United States.
- An NDA provides extensive data from non-clinical and clinical studies to establish the safety, efficacy, and appropriate labeling of the drug. It includes chemistry, manufacturing, and controls information as well as clinical data from Phase I-III trials.
- The goals of an NDA are to determine if the drug's benefits outweigh its risks, if its proposed labeling is appropriate, and if the methods used to manufacture and ensure the drug's quality are adequate.Ichguidelines imp
Ichguidelines impPRANJAY PATIL
Ìý
The ICH is an international body that works to harmonize technical requirements for pharmaceutical registration. Its goal is to ensure safe, effective and high quality medicines and to reduce unnecessary duplication of clinical trials. The ICH involves regulators and industry representatives from the EU, Japan and US. Key objectives include increasing international harmonization and developing pharmaceuticals efficiently.Hazard assessment and risk management techniques
Hazard assessment and risk management techniquesPRANJAY PATIL
Ìý
This document provides a summary of hazard assessment and risk management techniques for industries. It discusses key concepts like disaster risk management, disaster risk reduction, system safety, chemical hazards, hazard analysis at various stages of a project, and process hazard management. Specific techniques covered include process hazard analysis (PHA), HAZID, management of change (MOC), Dow and Mond indices, and consequence analysis. Formulas are provided for calculating indices to assess hazard severity and risk. Models for analyzing consequences of accidents like BLEVE are also summarized.Documentation in pharmaceutical industry
Documentation in pharmaceutical industryPRANJAY PATIL
Ìý
Pranjay Sadashiv Patil, a first year M.Pharm student, presented on documentation in pharmaceutical quality assurance. Documentation defines a system to minimize risks from misinterpretation or errors in oral communication. It includes specifications, test procedures, distribution records, and electronic data handling. Specifications provide parameters and limits for materials, equipment, and products. Test procedures must validate compliance to the end of shelf life. Controlled documents require approval and management of changes, while uncontrolled copies are for reference with a watermark.Defect clasification
Defect clasificationPRANJAY PATIL
Ìý
This document provides a classification of defects that can occur in pharmaceutical products. It defines a defect as an imperfection that causes a product to fail to meet specifications. Defects are classified based on their measurability (variable or attributive), seriousness (critical, major, or minor), and nature (ocular, internal, or performance). The document also discusses defect classifications used by the Pharmaceutical Quality System and the UK Medicines and Healthcare products Regulatory Agency, and lists some common root causes of deficiencies in a pharmaceutical quality system.Auditing of vendors and production department
Auditing of vendors and production departmentPRANJAY PATIL
Ìý
The document discusses vendor audits in the pharmaceutical industry. It provides details on the objectives, parameters, and steps of conducting a vendor audit. The key points are:
- Vendor audits assess a vendor's quality management system, practices, documentation, and adherence to standards to ensure their products and services meet requirements.
- Important parameters reviewed include ISO certifications, manufacturing facilities, packaging and labeling standards, and data handling procedures.
- The goals are to evaluate quality control measures and management commitment to quality standards required by regulations.
- Conducting vendor audits helps reduce costs and risks by gaining insight into supplier processes and compliance.Validation utility system
Validation utility systemPRANJAY PATIL
Ìý
This document discusses the validation of critical utility systems used in pharmaceutical manufacturing facilities. It covers the validation of HVAC systems, water systems, steam systems, compressed air systems, and nitrogen gas systems. For each system, it provides an overview and discusses the user requirements, design qualification, installation qualification, operational qualification, and performance qualification protocols. The validation aims to ensure these utility systems meet quality standards and specifications to support the manufacturing of safe and effective pharmaceutical products.Intellectual property rights (ipr)
Intellectual property rights (ipr)PRANJAY PATIL
Ìý
This document provides an overview of intellectual property rights (IPR) and various types of IPR protections. It defines IPR as exclusive rights granted by states to protect inventions, designs, trademarks, and original works. The document then discusses key types of IPR protections including patents, trademarks, industrial designs, copyright, trade secrets, and geographical indications. It provides examples and details on requirements for each type. The document aims to educate about IPR and facilitate discussion on related topics.Analytical method validation 2020
Analytical method validation 2020PRANJAY PATIL
Ìý
This document provides a summary of analytical method validation. It discusses the types of analytical procedures that should be validated, including identification tests, quantitative impurity tests, limit tests, and active moiety assays. It also summarizes key validation characteristics that should be considered, such as accuracy, precision, specificity, range, detection limit, quantitation limit, linearity, and robustness. The document provides definitions and methodology recommendations for validating analytical procedures. It emphasizes that the validation process verifies that an analytical method is suitable for its intended purpose.Process anaytical technology
Process anaytical technologyPRANJAY PATIL
Ìý
This document summarizes a presentation on Process Analytical Technology (PAT). It defines PAT as a system for designing, analyzing, and controlling manufacturing through timely measurements of critical quality attributes during processing. The goals of PAT are to build quality into products, enhance process understanding and control, and reduce process variation. It discusses types of PAT implementation, applications of PAT in different process steps, advantages like reduced cycle time and human error, and disadvantages like high costs. It also covers the PAT regulatory approach and guidance.Plant layout
Plant layoutPRANJAY PATIL
Ìý
This document discusses plant layout for pharmaceutical manufacturing facilities. It begins by defining plant layout and its importance for efficient production. There are two main types of layouts: process/functional layout which groups similar machines together and product/straight line layout which arranges machines in the order of operations. Key factors that influence layout include the production process, available space, operational convenience, and regulatory requirements. Special provisions for pharmaceutical facilities include preventing confusion or contamination. Storage areas for raw materials and finished goods are also discussed, including specific storage requirements. The document concludes by outlining the layout of sterile or aseptic manufacturing areas which separate different operations and control air flow and personnel movement to maintain sterility. production planning
production planningPRANJAY PATIL
Ìý
This document discusses various aspects of production planning and control in the pharmaceutical industry. It defines key terms like production planning, routing, loading, scheduling, dispatching. It describes the importance of production planning for procuring raw materials and tools in a timely manner. It explains different types of production systems like continuous, intermittent, batch production. Overall, the document provides an overview of the production planning and control process in the pharmaceutical industry.Quality assurance tools & techniques
Quality assurance tools & techniquesPRANJAY PATIL
Ìý
This document discusses concepts of quality assurance in the pharmaceutical industry. It begins with definitions of quality assurance from WHO and ISO. It then discusses the concept of quality assurance, covering all aspects that influence drug quality. Advantages include ensuring high quality drugs while disadvantages include perfection being difficult. Quality assurance tools discussed include total quality management, quality control systems, documentation, validation, and Six Sigma methodology. Total quality management aims to continuously improve quality through participation at all levels. Quality control systems involve qualified staff and standardized procedures. Documentation and validation are important for defining systems and ensuring quality. Six Sigma uses a data-driven approach to reduce defects and improve processes.Standard operating procedure 
Standard operating procedure PRANJAY PATIL
Ìý
This document provides guidance on standard operating procedures (SOPs). It defines SOPs and discusses their purpose and benefits. Key points include:
- SOPs are written instructions that document routine activities and ensure consistency. Their development is integral to a successful quality system.
- SOPs should describe technical and operational elements, and be specific to each organization. They facilitate adherence to requirements and support data quality.
- The document outlines best practices for SOP content, writing style, preparation, review, revision, formatting, and types. It emphasizes clear, step-by-step instructions to ensure consistent implementation.Packging material 
Packging material PRANJAY PATIL
Ìý
This document discusses pharmaceutical packaging materials and quality control testing. It defines primary, secondary, and tertiary packaging. Common materials used include glass, plastic, rubber, and paper. Quality control tests are described for glass including powdered glass and water attack tests. Plastic container tests include leakage, collapsibility, water vapor permeability, and transparency. Rubber closure tests include fragmentation, self-sealability, extractive, and compatibility testing. Proper packaging protects pharmaceutical products and quality testing ensures the materials are suitable for drug products.Packaging material
Packaging materialPRANJAY PATIL
Ìý
This document discusses pharmaceutical packaging materials. It begins by defining pharmaceutical packaging and listing the key characteristics packaging materials must have, such as protecting the product from environmental conditions and not being reactive.
It then describes the different types of packaging - primary, secondary, and tertiary. Primary packaging is in direct contact with the product, secondary protects both the primary and product, and tertiary is removed before retail display.
The document goes on to classify packaging materials and containers. It discusses common materials like glass, plastic, and metals, providing details on types within each category. It also covers biological testing and considerations for drug-plastic interactions. In closing, it thanks the audience and cites references used.Cpcsea
CpcseaPRANJAY PATIL
Ìý
This document provides guidelines for laboratory animal care and handling from the Committee for the Purpose of Control and Supervision of Experiments on Animals (CPCSEA). It discusses the composition and goals of CPCSEA, which provides guidelines and oversight of research projects using animals. The guidelines cover veterinary care, animal procurement, housing requirements, transportation, record keeping, and other aspects of humane animal research. CPCSEA aims to balance animal welfare with advancing biological knowledge.Analysis of raw material and finished product
Analysis of raw material and finished productPRANJAY PATIL
Ìý
This document summarizes key aspects of raw materials, quality control processes, and specifications for pharmaceutical products. It discusses criteria for selecting raw materials, roles of quality control in raw materials and finished products, and how specifications are developed and tested against. The summary focuses on establishing quality standards and controls from raw material selection through finished product release to ensure safety and efficacy.Non sterile manufacturing process technology
Non sterile manufacturing process technologyPRANJAY PATIL
Ìý
This document provides an overview of in-process quality control (IPQC) tests for non-sterile pharmaceutical tablets and capsules. It discusses the importance of IPQC in minimizing errors and enforcing manufacturing standards. Common IPQC tests described for tablets include weight variation, content uniformity, hardness, thickness, friability, dissolution, disintegration, and moisture content. For capsules, discussed tests include content of active ingredients, weight variation, content uniformity, disintegration, and dissolution. A variety of apparatus used in conducting these tests are also outlined.Coating technology
Coating technologyPRANJAY PATIL
Ìý
This document provides information about coating technology. It discusses various coating principles, processes, equipment, and applications. Specifically, it describes sugar coating and film coating processes, common coating equipment like standard coating pans and fluidized bed coaters, and particle coating techniques like microencapsulation and spray drying. It aims to explain how coating is used to modify drug release profiles and protect pharmaceutical products.C gmp
C gmpPRANJAY PATIL
Ìý
This document provides an overview of Good Manufacturing Practices (GMP) and current GMP (cGMP). It discusses what GMP and cGMP are, the key aspects they cover, the ten principles of GMP, important GMP documents, and Schedule M which outlines GMP requirements for pharmaceutical manufacturing in India. Schedule M includes requirements for factory premises, production areas, warehousing, personnel, sanitation and other key aspects to help ensure quality standards during manufacturing. aseptic process technology
aseptic process technologyPRANJAY PATIL
Ìý
This document provides information on aseptic processing technology and quality control testing for various sterile pharmaceutical dosage forms including ointments, suspensions, emulsions, and sterile solutions. It discusses cleanroom classifications, manufacturing processes, and in-process quality control tests for content uniformity, clarity, leakage, extractable volume, sterility, consistency, penetration, irritation potential, sedimentation, redispersibility, particle size, viscosity, and zeta potential.Non sterile manufacturing process technology
Non sterile manufacturing process technologyPRANJAY PATIL
Ìý
This document provides an overview of in-process quality control (IPQC) tests for tablets and capsules during the manufacturing process. It discusses the importance and scope of IPQC, as well as general IPQC tests such as identity, quality, purity, and potency tests. Specific IPQC tests covered for tablets include weight variation, content uniformity, hardness, thickness, friability, dissolution, disintegration, and moisture content. For capsules, content of active ingredients, weight variation, content uniformity, disintegration, dissolution, and moisture permeation are discussed. Various apparatus used to perform these tests are also described.How to use Init Hooks in Odoo 18 - Odoo ºÝºÝߣs
How to use Init Hooks in Odoo 18 - Odoo ºÝºÝߣsCeline George
Ìý
In this slide, we’ll discuss on how to use Init Hooks in Odoo 18. In Odoo, Init Hooks are essential functions specified as strings in the __init__ file of a module.
More Related Content
More from PRANJAY PATIL (20)
Documentation in pharmaceutical industry
Documentation in pharmaceutical industryPRANJAY PATIL
Ìý
Pranjay Sadashiv Patil, a first year M.Pharm student, presented on documentation in pharmaceutical quality assurance. Documentation defines a system to minimize risks from misinterpretation or errors in oral communication. It includes specifications, test procedures, distribution records, and electronic data handling. Specifications provide parameters and limits for materials, equipment, and products. Test procedures must validate compliance to the end of shelf life. Controlled documents require approval and management of changes, while uncontrolled copies are for reference with a watermark.Defect clasification
Defect clasificationPRANJAY PATIL
Ìý
This document provides a classification of defects that can occur in pharmaceutical products. It defines a defect as an imperfection that causes a product to fail to meet specifications. Defects are classified based on their measurability (variable or attributive), seriousness (critical, major, or minor), and nature (ocular, internal, or performance). The document also discusses defect classifications used by the Pharmaceutical Quality System and the UK Medicines and Healthcare products Regulatory Agency, and lists some common root causes of deficiencies in a pharmaceutical quality system.Auditing of vendors and production department
Auditing of vendors and production departmentPRANJAY PATIL
Ìý
The document discusses vendor audits in the pharmaceutical industry. It provides details on the objectives, parameters, and steps of conducting a vendor audit. The key points are:
- Vendor audits assess a vendor's quality management system, practices, documentation, and adherence to standards to ensure their products and services meet requirements.
- Important parameters reviewed include ISO certifications, manufacturing facilities, packaging and labeling standards, and data handling procedures.
- The goals are to evaluate quality control measures and management commitment to quality standards required by regulations.
- Conducting vendor audits helps reduce costs and risks by gaining insight into supplier processes and compliance.Validation utility system
Validation utility systemPRANJAY PATIL
Ìý
This document discusses the validation of critical utility systems used in pharmaceutical manufacturing facilities. It covers the validation of HVAC systems, water systems, steam systems, compressed air systems, and nitrogen gas systems. For each system, it provides an overview and discusses the user requirements, design qualification, installation qualification, operational qualification, and performance qualification protocols. The validation aims to ensure these utility systems meet quality standards and specifications to support the manufacturing of safe and effective pharmaceutical products.Intellectual property rights (ipr)
Intellectual property rights (ipr)PRANJAY PATIL
Ìý
This document provides an overview of intellectual property rights (IPR) and various types of IPR protections. It defines IPR as exclusive rights granted by states to protect inventions, designs, trademarks, and original works. The document then discusses key types of IPR protections including patents, trademarks, industrial designs, copyright, trade secrets, and geographical indications. It provides examples and details on requirements for each type. The document aims to educate about IPR and facilitate discussion on related topics.Analytical method validation 2020
Analytical method validation 2020PRANJAY PATIL
Ìý
This document provides a summary of analytical method validation. It discusses the types of analytical procedures that should be validated, including identification tests, quantitative impurity tests, limit tests, and active moiety assays. It also summarizes key validation characteristics that should be considered, such as accuracy, precision, specificity, range, detection limit, quantitation limit, linearity, and robustness. The document provides definitions and methodology recommendations for validating analytical procedures. It emphasizes that the validation process verifies that an analytical method is suitable for its intended purpose.Process anaytical technology
Process anaytical technologyPRANJAY PATIL
Ìý
This document summarizes a presentation on Process Analytical Technology (PAT). It defines PAT as a system for designing, analyzing, and controlling manufacturing through timely measurements of critical quality attributes during processing. The goals of PAT are to build quality into products, enhance process understanding and control, and reduce process variation. It discusses types of PAT implementation, applications of PAT in different process steps, advantages like reduced cycle time and human error, and disadvantages like high costs. It also covers the PAT regulatory approach and guidance.Plant layout
Plant layoutPRANJAY PATIL
Ìý
This document discusses plant layout for pharmaceutical manufacturing facilities. It begins by defining plant layout and its importance for efficient production. There are two main types of layouts: process/functional layout which groups similar machines together and product/straight line layout which arranges machines in the order of operations. Key factors that influence layout include the production process, available space, operational convenience, and regulatory requirements. Special provisions for pharmaceutical facilities include preventing confusion or contamination. Storage areas for raw materials and finished goods are also discussed, including specific storage requirements. The document concludes by outlining the layout of sterile or aseptic manufacturing areas which separate different operations and control air flow and personnel movement to maintain sterility. production planning
production planningPRANJAY PATIL
Ìý
This document discusses various aspects of production planning and control in the pharmaceutical industry. It defines key terms like production planning, routing, loading, scheduling, dispatching. It describes the importance of production planning for procuring raw materials and tools in a timely manner. It explains different types of production systems like continuous, intermittent, batch production. Overall, the document provides an overview of the production planning and control process in the pharmaceutical industry.Quality assurance tools & techniques
Quality assurance tools & techniquesPRANJAY PATIL
Ìý
This document discusses concepts of quality assurance in the pharmaceutical industry. It begins with definitions of quality assurance from WHO and ISO. It then discusses the concept of quality assurance, covering all aspects that influence drug quality. Advantages include ensuring high quality drugs while disadvantages include perfection being difficult. Quality assurance tools discussed include total quality management, quality control systems, documentation, validation, and Six Sigma methodology. Total quality management aims to continuously improve quality through participation at all levels. Quality control systems involve qualified staff and standardized procedures. Documentation and validation are important for defining systems and ensuring quality. Six Sigma uses a data-driven approach to reduce defects and improve processes.Standard operating procedure
Standard operating procedure PRANJAY PATIL
Ìý
This document provides guidance on standard operating procedures (SOPs). It defines SOPs and discusses their purpose and benefits. Key points include:
- SOPs are written instructions that document routine activities and ensure consistency. Their development is integral to a successful quality system.
- SOPs should describe technical and operational elements, and be specific to each organization. They facilitate adherence to requirements and support data quality.
- The document outlines best practices for SOP content, writing style, preparation, review, revision, formatting, and types. It emphasizes clear, step-by-step instructions to ensure consistent implementation.Packging material
Packging material PRANJAY PATIL
Ìý
This document discusses pharmaceutical packaging materials and quality control testing. It defines primary, secondary, and tertiary packaging. Common materials used include glass, plastic, rubber, and paper. Quality control tests are described for glass including powdered glass and water attack tests. Plastic container tests include leakage, collapsibility, water vapor permeability, and transparency. Rubber closure tests include fragmentation, self-sealability, extractive, and compatibility testing. Proper packaging protects pharmaceutical products and quality testing ensures the materials are suitable for drug products.Packaging material
Packaging materialPRANJAY PATIL
Ìý
This document discusses pharmaceutical packaging materials. It begins by defining pharmaceutical packaging and listing the key characteristics packaging materials must have, such as protecting the product from environmental conditions and not being reactive.
It then describes the different types of packaging - primary, secondary, and tertiary. Primary packaging is in direct contact with the product, secondary protects both the primary and product, and tertiary is removed before retail display.
The document goes on to classify packaging materials and containers. It discusses common materials like glass, plastic, and metals, providing details on types within each category. It also covers biological testing and considerations for drug-plastic interactions. In closing, it thanks the audience and cites references used.Cpcsea
CpcseaPRANJAY PATIL
Ìý
This document provides guidelines for laboratory animal care and handling from the Committee for the Purpose of Control and Supervision of Experiments on Animals (CPCSEA). It discusses the composition and goals of CPCSEA, which provides guidelines and oversight of research projects using animals. The guidelines cover veterinary care, animal procurement, housing requirements, transportation, record keeping, and other aspects of humane animal research. CPCSEA aims to balance animal welfare with advancing biological knowledge.Analysis of raw material and finished product
Analysis of raw material and finished productPRANJAY PATIL
Ìý
This document summarizes key aspects of raw materials, quality control processes, and specifications for pharmaceutical products. It discusses criteria for selecting raw materials, roles of quality control in raw materials and finished products, and how specifications are developed and tested against. The summary focuses on establishing quality standards and controls from raw material selection through finished product release to ensure safety and efficacy.Non sterile manufacturing process technology
Non sterile manufacturing process technologyPRANJAY PATIL
Ìý
This document provides an overview of in-process quality control (IPQC) tests for non-sterile pharmaceutical tablets and capsules. It discusses the importance of IPQC in minimizing errors and enforcing manufacturing standards. Common IPQC tests described for tablets include weight variation, content uniformity, hardness, thickness, friability, dissolution, disintegration, and moisture content. For capsules, discussed tests include content of active ingredients, weight variation, content uniformity, disintegration, and dissolution. A variety of apparatus used in conducting these tests are also outlined.Coating technology
Coating technologyPRANJAY PATIL
Ìý
This document provides information about coating technology. It discusses various coating principles, processes, equipment, and applications. Specifically, it describes sugar coating and film coating processes, common coating equipment like standard coating pans and fluidized bed coaters, and particle coating techniques like microencapsulation and spray drying. It aims to explain how coating is used to modify drug release profiles and protect pharmaceutical products.C gmp
C gmpPRANJAY PATIL
Ìý
This document provides an overview of Good Manufacturing Practices (GMP) and current GMP (cGMP). It discusses what GMP and cGMP are, the key aspects they cover, the ten principles of GMP, important GMP documents, and Schedule M which outlines GMP requirements for pharmaceutical manufacturing in India. Schedule M includes requirements for factory premises, production areas, warehousing, personnel, sanitation and other key aspects to help ensure quality standards during manufacturing. aseptic process technology
aseptic process technologyPRANJAY PATIL
Ìý
This document provides information on aseptic processing technology and quality control testing for various sterile pharmaceutical dosage forms including ointments, suspensions, emulsions, and sterile solutions. It discusses cleanroom classifications, manufacturing processes, and in-process quality control tests for content uniformity, clarity, leakage, extractable volume, sterility, consistency, penetration, irritation potential, sedimentation, redispersibility, particle size, viscosity, and zeta potential.Non sterile manufacturing process technology
Non sterile manufacturing process technologyPRANJAY PATIL
Ìý
This document provides an overview of in-process quality control (IPQC) tests for tablets and capsules during the manufacturing process. It discusses the importance and scope of IPQC, as well as general IPQC tests such as identity, quality, purity, and potency tests. Specific IPQC tests covered for tablets include weight variation, content uniformity, hardness, thickness, friability, dissolution, disintegration, and moisture content. For capsules, content of active ingredients, weight variation, content uniformity, disintegration, dissolution, and moisture permeation are discussed. Various apparatus used to perform these tests are also described.Recently uploaded (20)
How to use Init Hooks in Odoo 18 - Odoo ºÝºÝߣs
How to use Init Hooks in Odoo 18 - Odoo ºÝºÝߣsCeline George
Ìý
In this slide, we’ll discuss on how to use Init Hooks in Odoo 18. In Odoo, Init Hooks are essential functions specified as strings in the __init__ file of a module.Eng7-Q4-Lesson 1 Part 1 Understanding Discipline-Specific Words, Voice, and T...
Eng7-Q4-Lesson 1 Part 1 Understanding Discipline-Specific Words, Voice, and T...sandynavergas1
Ìý
Understanding Discipline-Specific Words, Voice, and Technical TermsHow to Modify Existing Web Pages in Odoo 18
How to Modify Existing Web Pages in Odoo 18Celine George
Ìý
In this slide, we’ll discuss on how to modify existing web pages in Odoo 18. Web pages in Odoo 18 can also gather user data through user-friendly forms, encourage interaction through engaging features. Mate, a short story by Kate Grenvile.pptx
Mate, a short story by Kate Grenvile.pptxLiny Jenifer
Ìý
A powerpoint presentation on the short story Mate by Kate Greenville. This presentation provides information on Kate Greenville, a character list, plot summary and critical analysis of the short story.Kaun TALHA quiz Prelims - El Dorado 2025
Kaun TALHA quiz Prelims - El Dorado 2025Conquiztadors- the Quiz Society of Sri Venkateswara College
Ìý
Prelims of Kaun TALHA : a Travel, Architecture, Lifestyle, Heritage and Activism quiz, organized by Conquiztadors, the Quiz society of Sri Venkateswara College under their annual quizzing fest El Dorado 2025. 
Year 10 The Senior Phase Session 3 Term 1.pptx
Year 10 The Senior Phase Session 3 Term 1.pptxmansk2
Ìý
Year 10 The Senior Phase Session 3 Term 1.pptxEDL 290F Week 3 - Mountaintop Views (2025).pdf
EDL 290F Week 3 - Mountaintop Views (2025).pdfLiz Walsh-Trevino
Ìý
EDL 290F Week 3 - Mountaintop Views (2025).pdfAdventure Activities Final By H R Gohil Sir
Adventure Activities Final By H R Gohil SirGUJARATCOMMERCECOLLE
Ìý
Adventure Activities Final By H R Gohil Sir
Blind spots in AI and Formulation Science, IFPAC 2025.pdf
Blind spots in AI and Formulation Science, IFPAC 2025.pdfAjaz Hussain
Ìý
The intersection of AI and pharmaceutical formulation science highlights significant blind spots—systemic gaps in pharmaceutical development, regulatory oversight, quality assurance, and the ethical use of AI—that could jeopardize patient safety and undermine public trust. To move forward effectively, we must address these normalized blind spots, which may arise from outdated assumptions, errors, gaps in previous knowledge, and biases in language or regulatory inertia. This is essential to ensure that AI and formulation science are developed as tools for patient-centered and ethical healthcare.
APM People Interest Network Conference - Tim Lyons - The neurological levels ...
APM People Interest Network Conference - Tim Lyons - The neurological levels ...Association for Project Management
Ìý
APM People Interest Network Conference 2025
-Autonomy, Teams and Tension: Projects under stress
-Tim Lyons
-The neurological levels of
team-working: Harmony and tensions
With a background in projects spanning more than 40 years, Tim Lyons specialised in the delivery of large, complex, multi-disciplinary programmes for clients including Crossrail, Network Rail, ExxonMobil, Siemens and in patent development. His first career was in broadcasting, where he designed and built commercial radio station studios in Manchester, Cardiff and Bristol, also working as a presenter and programme producer. Tim now writes and presents extensively on matters relating to the human and neurological aspects of projects, including communication, ethics and coaching. He holds a Master’s degree in NLP, is an NLP Master Practitioner and International Coach. He is the Deputy Lead for APM’s People Interest Network.
Session | The Neurological Levels of Team-working: Harmony and Tensions
Understanding how teams really work at conscious and unconscious levels is critical to a harmonious workplace. This session uncovers what those levels are, how to use them to detect and avoid tensions and how to smooth the management of change by checking you have considered all of them.How to Configure Flexible Working Schedule in Odoo 18 Employee
How to Configure Flexible Working Schedule in Odoo 18 EmployeeCeline George
Ìý
In this slide, we’ll discuss on how to configure flexible working schedule in Odoo 18 Employee module. In Odoo 18, the Employee module offers powerful tools to configure and manage flexible working schedules tailored to your organization's needs.FESTIVAL: SINULOG & THINGYAN-LESSON 4.pptx
FESTIVAL: SINULOG & THINGYAN-LESSON 4.pptxDanmarieMuli1
Ìý
Sinulog Festival of Cebu City, and Thingyan Festival of Myanmar.
Kaun TALHA quiz Prelims - El Dorado 2025
Kaun TALHA quiz Prelims - El Dorado 2025Conquiztadors- the Quiz Society of Sri Venkateswara College
Ìý
APM People Interest Network Conference - Tim Lyons - The neurological levels ...
APM People Interest Network Conference - Tim Lyons - The neurological levels ...Association for Project Management
Ìý
New ir spectroscopy
- 1. • PRESENTD BY :- • PATIL PRANJAY SADASHIV. • FIRST YEAR M.PHARM. • DEPARTMENT OF QUALITY ASSURANCE. H. R. Patel Institute of Pharmaceutical Education and Research, Shirpur IR spectroscopy